Literature DB >> 12485746

PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption.

Patrizia Brigidi1, Erwin Swennen, Beatrice Vitali, Maddalena Rossi, Diego Matteuzzi.   

Abstract

Streptococcus thermophilus, Bifidobacterium infantis Y1 and Bifidobacterium breve Y8 strains were identified and enumerated by PCR assay in human fecal samples after intake of the pharmaceutical preparation VSL-3 or yogurt. ThI/ThII primer set, specific for S. thermophilus, was selected testing its specificity against several strains of enterococci, streptococci and other genera colonizing the human intestine. A culture-independent PCR protocol, developed in this study, allowed to directly detect and enumerate S. thermophilus in human feces, excluding culture-based techniques or time consuming DNA isolation and purification procedures. Intestinal persistence of S. thermophilus was studied in feces of 10 healthy subjects given VSL-3 or yogurt. Streptococcal population was detected after 3 days of administration and persisted for 6 days after the treatment suspension. In the same trial, the colonization kinetics of B. infantis Y1 and B. breve Y8 were studied by amplification of colonies with the strain-specific primer sets InfY-BV.L/R and BreY-BV.R/L, showing a host-dependent transient colonization behaviour. PCR analysis of feces from 10 patients affected by inflammatory bowel diseases (IBD) and treated with VSL-3 for 2 months showed a colonization pattern of S. thermophilus, B. infantis Y1 and B. breve Y8 similar to that observed with the healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12485746     DOI: 10.1016/s0168-1605(02)00245-3

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  15 in total

1.  Fermented milk-starch and milk-inulin products as vehicles for lactic acid bacteria.

Authors:  Angela Zuleta; María I Sarchi; María E Rio; María E Sambucetti
Journal:  Plant Foods Hum Nutr       Date:  2004       Impact factor: 3.921

2.  Survival of yogurt bacteria in the human gut.

Authors:  Marina Elli; Maria Luisa Callegari; Susanna Ferrari; Elena Bessi; Daniela Cattivelli; Sara Soldi; Lorenzo Morelli; Nathalie Goupil Feuillerat; Jean-Michel Antoine
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

3.  Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects.

Authors:  Joseph Okombo; Michael Liebman
Journal:  Urol Res       Date:  2010-03-12

Review 4.  VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.

Authors:  Therese M Chapman; Greg L Plosker; David P Figgitt
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Irritable bowel syndrome: bacteria and inflammation--clinical relevance now.

Authors:  Robin C Spiller
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

6.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

7.  p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.

Authors:  Hye Sun Hyun; Kyung Hoon Paik; Hee Yeon Cho
Journal:  Korean J Pediatr       Date:  2013-04-22

8.  Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial.

Authors:  İlkay Yılmaz; M Enver Dolar; Haydar Özpınar
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

9.  Congruent strain specific intestinal persistence of Lactobacillus plantarum in an intestine-mimicking in vitro system and in human volunteers.

Authors:  Hermien van Bokhorst-van de Veen; Iris van Swam; Michiel Wels; Peter A Bron; Michiel Kleerebezem
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

10.  Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation.

Authors:  Rachel C Anderson; Adrian L Cookson; Warren C McNabb; Zaneta Park; Mark J McCann; William J Kelly; Nicole C Roy
Journal:  BMC Microbiol       Date:  2010-12-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.